Nothing Special   »   [go: up one dir, main page]

Lv et al., 2013 - Google Patents

Galactose substituted zinc phthalocyanines as near infrared fluorescence probes for liver cancer imaging

Lv et al., 2013

Document ID
12223147053568326905
Author
Lv F
Li Y
Cao B
Liu T
Publication year
Publication venue
Journal of Materials Science: Materials in Medicine

External Links

Snippet

Galactose substituted with zinc phthalocyanines were synthesized and characterized as near infrared fluorescent probes. The probes have good water-solubility and high emission ability in the near infrared region. With nudemice bearing liver cancer as models, in vivo …
Continue reading at link.springer.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group the fluorescent group being a small organic molecule
    • A61K49/0036—Porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0058—Antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent

Similar Documents

Publication Publication Date Title
Kim et al. In vivo imaging of β-galactosidase stimulated activity in hepatocellular carcinoma using ligand-targeted fluorescent probe
Chen et al. A low molecular weight PSMA-based fluorescent imaging agent for cancer
Lv et al. Galactose substituted zinc phthalocyanines as near infrared fluorescence probes for liver cancer imaging
Usama et al. Hows and whys of tumor-seeking dyes
Luo et al. A multifunctional heptamethine near-infrared dye for cancer theranosis
Zhang et al. Bioorthogonally activatable cyanine dye with torsion-induced disaggregation for in vivo tumor imaging
Lv et al. Lactose substituted zinc phthalocyanine: A near infrared fluorescence imaging probe for liver cancer targeting
Wu et al. Modular design of high-brightness pH-activatable near-infrared BODIPY probes for noninvasive fluorescence detection of deep-seated early breast cancer bone metastasis: remarkable axial substituent effect on performance
Zhang et al. Monomolecular multimodal fluorescence-radioisotope imaging agents
Pavlik et al. Synthesis and fluorescent characteristics of imidazole–indocyanine green conjugates
Lv et al. Synthesis, properties and near-infrared imaging evaluation of glucose conjugated zinc phthalocyanine via Click reaction
Zheng et al. Intra-and intermolecular synergistic engineering of aggregation-induced emission luminogens to boost three-photon absorption for through-skull brain imaging
US8293782B2 (en) Compound, probe containing the novel compound, and fluorescence-imaging contrast agent containing the novel compound or the probe
CN103003282A (en) A process for the preparation of novel porphyrin derivatives and their use as PDT agents and fluorescence probes
Zhou et al. Targeting tumor hypoxia: a third generation 2-nitroimidazole-indocyanine dye-conjugate with improved fluorescent yield
Zhuang et al. A lipid droplet specific fluorescent probe for image-guided photodynamic therapy under hypoxia
Shimizu et al. Development of novel nanocarrier-based near-infrared optical probes for in vivo tumor imaging
Privat et al. Development of an easily bioconjugatable water-soluble single-photon emission-computed tomography/optical imaging bimodal imaging probe based on the aza-BODIPY fluorophore
Stammes et al. Pre-clinical evaluation of a cyanine-based SPECT probe for multimodal tumor necrosis imaging
Mai et al. Improved IR780 derivatives bearing morpholine group as tumor-targeted therapeutic agent for near-infrared fluorescence imaging and photodynamic therapy
Ma et al. An imidazole-derived polarity sensitive probe for lipid droplet target and in vivo tumor imaging
Xiong et al. A benzophenoxazine-dyad as cancer indicator using for fluorescence-guided phototherapy
ES2718835T3 (en) Near infrared fluorescent dyes (NIR)
Mahounga et al. Synthesis of a novel L-methyl-methionine–ICG-Der-02 fluorescent probe for in vivo near infrared imaging of tumors
Li et al. A live cell tracking NIR bioprobe for lung cancer cell metastasis monitoring